Leadless Pacemaker Trial Requirements Come Under FDA Panel Scrutiny
This article was originally published in The Gray Sheet
Executive Summary
The agency's Circulatory System Devices panel will consider clinical study requirements for the nascent class of pacemakers lacking the leads that cause complications in conventional devices.